ELOX: Eloxx Pharmaceuticals, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | New 13G stake | Samsara BioCapital, L.P. | 9.90% | SEC | |
| 2026-08-14 | New 13G stake | Nantahala Capital Management, LLC | 9.91% | SEC | |
| 2026-07-27 | New 13G stake | Aberdeen Group plc | 9.91% | SEC |
Institutional ownership (Q2 2026)
22 institutions reported holding $40.25M of Eloxx Pharmaceuticals, Inc. on Form 13F (0 the quarter before). 22 opened a new position and 0 sold out. Shares held by institutions: new.
| Largest holders | Shares | Value |
|---|---|---|
| Nantahala Capital Management, LLC | 800,000 | $11.10M |
| EcoR1 Capital, LLC | 400,000 | $5.55M |
| Aberdeen Group plc | 400,000 | $5.55M |
| SAMSARA BIOCAPITAL, LLC | 400,000 | $5.55M |
| Siren, L.L.C. | 400,000 | $5.55M |
| Stonepine Capital Management, LLC | 397,160 | $5.51M |
| VANGUARD CAPITAL MANAGEMENT LLC | 78,680 | $1.09M |
| VANGUARD FIDUCIARY TRUST CO | 10,602 | $147K |
| SEVEN GRAND MANAGERS, LLC | 10,000 | $139K |
| MORGAN STANLEY | 1,544 | $21K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.